About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Periodic Versus Continuous IV Iron Supplementation in HD Patients

Periodic Versus Continuous IV Iron Supplementation in HD Patients

NCT02787824·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Papageorgiou General Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Constant rHu-EPO and iron dose for at least 2 months before starting the study
Hemoglobin ≥ 8,5g/dl and \<12,5 g/dl
Ferritin \< 1000 mg/dl
TSAT \< 50%
CRP \< 5 mg/dl

You may not be if

Malignant tumor disease
Oral iron supplementation
Active bleeding issues
Surgical intervention within the last 8 weeks before study inclusion

The record

StatusCompleted

PhasePhase 4

Taking part27

StartedMay 2016

UpdatedSep 20, 2017

Conditions

Anemia of Chronic Kidney Disease

Where1

Papageorgiou General Hospital
Thessaloniki, Greece